Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
With the advent of effective treatments for diabetic retinopathy (DR), a new era in the management of DR has been opened up. Amid the deluge of approved treatments and promising new strategies, however, clinicians may find it difficult to choose the appropriate practice in each individual case. The purpose of this easy-to-use and richly illustrated manual is to assist ophthalmologists in making decisions in the entire management of DR based on the best available evidence. Practical and complete recommendations are provided to guide clinicians in diagnosis, decision-making, and treatment. The…mehr
With the advent of effective treatments for diabetic retinopathy (DR), a new era in the management of DR has been opened up. Amid the deluge of approved treatments and promising new strategies, however, clinicians may find it difficult to choose the appropriate practice in each individual case. The purpose of this easy-to-use and richly illustrated manual is to assist ophthalmologists in making decisions in the entire management of DR based on the best available evidence. Practical and complete recommendations are provided to guide clinicians in diagnosis, decision-making, and treatment. The manual includes practical algorithms and case histories relating to all stages of DR that clearly explain the progression of the disease and will help the clinician to choose the best therapeutic approach. It will be an ideal resource for ophthalmologists aiming to provide optimal clinical management for this sight-threatening disease.
Francesco Bandello is Professor and Chairman of the Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy. He serves as Academic Dean at his University. He is President of Euretina, Vice President of Academia Ophthalmologica Europea, Fellow of the European Leadership Development Programme of the American Academy of Ophthalmology and a former Executive Committee Member of The Macula Society and of the Club Jules Gonin. Dr. Bandello is Associate Editor of the European Journal of Ophthalmology and Editor of Developments in Ophthalmology (Karger, Basel). Dr. Bandello is also an editorial board member of several other journals, including JAMA Ophthalmology, Case Reports in Ophthalmology, Journal of Ocular Pharmacology and Therapeutics and Ophthalmologica. He has been principal investigator in several clinical trials mainly focusing on age-related macular degeneration and diabetic retinopathy. Dr. Bandello has published 220 articles in peer-reviewed journals and is the co-author of seven books. Ilaria Zucchiatti studied at the Medical School at the University of Padova. She is currently a Consultant at the Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy, having previously completed her specialization in ophthalmology. Her specific research interest involves age related macular degeneration and diabetic retinopathy. She has been Study Coordinator for various randomized clinical trials relating to retinal diseases. Dr. Zucchiatti has to date authored sixteen articles in peer-reviewed journals. Rosangela Lattanzio is a member of the Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy and Head of the Medical Retina Service-Vasculopathies at San Raffaele Hospital. Since 2002 she has been an Editorial Associate of the European Journal of Ophthalmology. From 2008 to 2010, Dr. Lattanzio served on the Scientific Committee of the Italian Society of Ophthalmology. Her particular research interest is the retina (vasculopathies, diabetic retinopathy, retinal vein occlusions, etc.). She was awarded in 2004 Kreissig award-Euretina and in 2007 First Prize by the Italian Society of Ophthalmology for a research project. Dr. Lattanzio is an elected member of the Club Jules Gonin. She has been principal investigator or study coordinator in several clinical trials mainly focusing on retinal vasculopathies. Dr. Lattanzio is the author of numerous articles in peer-reviewed journals and is the co-author of one book.
Inhaltsangabe
Risk factors, Epidemiology and Pathophysiology of Diabetic Retinopathy.- Non Proliferative Diabetic Retinopathy.- Proliferative Diabetic Retinopathy.- Diabetic Macular Edema.- Advanced Proliferative Diabetic Retinopathy.